Effects of Newly Synthesized Recombinant Human Amyloid-β Complexes and Poly-Amyloid-β Fibers on Cell Apoptosis and Cognitive Decline
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The main pathological hallmark of Alzheimer’s disease is the deposition of amyloid-beta (Aβ) peptides in the brain. Aβ has been widely used to mimic several aspects of Alzheimer’s disease. However, several characteristics of amyloid-induced Alzheimer’s disease pathology are not well established, especially in mice. The present study aimed to develop a new Alzheimer’s disease model by investigating how Aβ can be effectively aggregated using prokaryotes and eukaryotes. To express the Aβ42 complex in HEK293 cells, we cloned the Aβ42 region in a tandem repeat and incorporated the resulting construct into a eukaryotic expression vector. Following transfection into HEK293 cells via lipofection, cell viability assay and western blotting analysis revealed that exogenous Aβ42 can induce cell death and apoptosis. In addition, recombinant His-tagged Aβ42 was successfully expressed in Escherichia coli BL21 (DE3) and not only readily formed Aβ complexes, but also inhibited the proliferation of SH-SY5Y cells and E. coli. For in vivo testing, recombinant His-tagged Aβ42 solution (3 μg/ μl in 1× PBS containing 1 mM Ni2+) was injected stereotaxically into the left and right lateral ventricles of the brains of C57BL/6J mice (n = 8). Control mice were injected with 1× PBS containing 1 mM Ni2+ following the same procedure. Ten days after the sample injection, the Morris water maze test confirmed that exogenous Aβ caused an increase in memory loss. These findings demonstrated that Ni2+ is capable of complexing the 50-kDa amyloid and that intracerebroventricular injection of Aβ42 can lead to cognitive impairment, thereby providing improved Alzheimer’s disease models.
Abstract
The main pathological hallmark of Alzheimer’s disease is the deposition of amyloid-beta (Aβ) peptides in the brain. Aβ has been widely used to mimic several aspects of Alzheimer’s disease. However, several characteristics of amyloid-induced Alzheimer’s disease pathology are not well established, especially in mice. The present study aimed to develop a new Alzheimer’s disease model by investigating how Aβ can be effectively aggregated using prokaryotes and eukaryotes. To express the Aβ42 complex in HEK293 cells, we cloned the Aβ42 region in a tandem repeat and incorporated the resulting construct into a eukaryotic expression vector. Following transfection into HEK293 cells via lipofection, cell viability assay and western blotting analysis revealed that exogenous Aβ42 can induce cell death and apoptosis. In addition, recombinant His-tagged Aβ42 was successfully expressed in Escherichia coli BL21 (DE3) and not only readily formed Aβ complexes, but also inhibited the proliferation of SH-SY5Y cells and E. coli. For in vivo testing, recombinant His-tagged Aβ42 solution (3 μg/ μl in 1× PBS containing 1 mM Ni2+) was injected stereotaxically into the left and right lateral ventricles of the brains of C57BL/6J mice (n = 8). Control mice were injected with 1× PBS containing 1 mM Ni2+ following the same procedure. Ten days after the sample injection, the Morris water maze test confirmed that exogenous Aβ caused an increase in memory loss. These findings demonstrated that Ni2+ is capable of complexing the 50-kDa amyloid and that intracerebroventricular injection of Aβ42 can lead to cognitive impairment, thereby providing improved Alzheimer’s disease models.
참고문헌 (26)
- Bose A, "Mitochondrial dysfunction in Parkinson’s disease", J. Neurochem, 139(Suppl 1), pp.216~231 (2016)
- LaFerla FM., "Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease", Nat. Rev. Neurosci, 3, pp.862~872 (2002)
- Sas K, "Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders", J. Neurol. Sci, 257, pp.221~239 (2007)
- Oakley H, "Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation", J. Neurosci, 26, pp.10129~10140 (2006)
- Morgan D, "A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease", Nature, 408, pp.982~985 (2000)
- Reaume AG, "Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer’s disease mutations and a 'humanized' Abeta sequence", J. Biol. Chem, 271, pp.23380~23388 (1996)
- Sisodia SS, "Role of the beta-amyloid protein in Alzheimer’s disease", FASEB J, 9, pp.366~370 (1995)
- Ekyune Kim, "Extracellular Domain of V-Set and Immunoglobulin Domain Containing 1 (VSIG1) Interacts with Ser-toli Cell Membrane Protein, while Its PDZ-Binding Motif Forms a Complex with ZO-1", Molecules and Cells, 30(5), pp.443~448 (2010), 한국분자세포생물학회
- Cui L, "Ferulic acid inhibits the transition of amyloid-beta42 monomers to oligomers but accelerates the transition from oligomers to fibrils", J. Alzheimers Dis, 37, pp.19~28 (2013)
- Du X, "Enterovirus 71 induces apoptosis of SHSY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression", Mol. Med. Rep, 12, pp.953~959 (2015)
- Kim E, "Differential localization of ADAM1a and ADAM1b in the endoplasmic reticulum of testicular germ cells and on the surface of epididymal sperm", Biochem. Biophys. Res. Commun, 304, pp.313~319 (2003)
- Kim E, "Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass", Proc. Natl. Acad. Sci. USA, 102, pp.18028~18033 (2005)
- Bradford MM., "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding", Anal. Biochem, 72, pp.248~254 (1976)
- Yue Lu, "Emodin Isolated from Polygoni cuspidati Radix Inhibits TNF-αand IL-6 Release by Blockading NF-κB and MAP Kinase Pathways in Mast Cells Stimulated with PMA Plus A23187", Biomolecules & Therapeutics, 21(6), pp.435~441 (2013), 한국응용약물학회
- Kerr MC, "A novel mammalian retromer component, Vps26B", Traffic, 6, pp.991~1001 (2005)
- Cao LH, "Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts", Sci. Rep, 6, pp.18706~ (2016)
- Song J, "Cordyceps militaris induces tumor cell death via the caspasedependent mitochondrial pathway in HepG2 and MCF7cells", Mol. Med. Rep, 13, pp.5132~5140 (2016)
- Zhao X, "Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms", Mol. Med. Rep, 14, pp.1067~1074 (2016)
- Wu MN, "Colivelin ameliorates amyloid beta peptide-induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats", Hippocampus, 25, pp.363~372 (2015)
- Zhou JM, "Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris", Virus Genes, 33, pp.27~32 (2006)
- Soscia SJ, "The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide", PLoS One, 5, pp.e9505~ (2010)
- McConlogue L, "Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice", J. Biol. Chem, 282, pp.26326~26334 (2007)
- Luo Y, "BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time", Neurobiol. Dis, 14, pp.81~88 (2003)
- Jaekwang Kim, "Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms", Molecules and Cells, 37(11), pp.767~776 (2014), 한국분자세포생물학회
- Haass C, "Trafficking and proteolytic processing of APP", Cold Spring Harb. Perspect. Med, 2, pp.a006270~ (2012)
- Campion D, "Alzheimer disease: modeling an Abetacentered biological network", Mol. Psychiatry, 21, pp.861~871 (2016)